Bill & Melinda Gates Foundation logo

Bill & Melinda Gates Foundation

North America, New York, United States, New York

Description

The Bill & Melinda Gates Foundation stands as one of the world's preeminent philanthropic organizations, established by Bill and Melinda Gates with a profound commitment to reducing inequity and improving lives globally. Unlike traditional venture capital firms, the Foundation operates primarily as a grant-making entity, channeling its vast resources towards addressing critical challenges in global health, poverty, and education. Its strategic approach is rooted in fostering innovation and delivering measurable impact, rather than seeking financial returns on its "investments."

With an endowment that has exceeded $50 billion, the Foundation possesses unparalleled financial capacity to fund ambitious initiatives worldwide. Since its inception, it has disbursed over $70 billion in grants, making it a monumental force in global development and humanitarian efforts. These funds are primarily directed towards non-profit organizations, research institutions, and, occasionally, for-profit entities whose work directly aligns with the Foundation's charitable objectives. Funding mechanisms include direct grants, as well as Program-Related Investments (PRIs), which are financial tools designed to achieve specific programmatic goals with a social return focus.

The Foundation's funding strategy is highly data-driven and outcomes-oriented, focusing on scalable solutions to complex global problems. It supports a diverse portfolio of initiatives, ranging from the development and distribution of vaccines to eradicate diseases like polio and malaria, to advancing agricultural productivity in developing nations, and improving educational outcomes. Their "investments" are characterized by a long-term perspective, aiming to create sustainable systemic change rather than short-term fixes.

While the Foundation does not issue "cheques" in the conventional venture capital sense, its funding amounts vary significantly based on the scope and nature of the project. Individual grants can range from approximately $50,000 for focused research projects or smaller-scale community initiatives, extending up to hundreds of millions of dollars for large-scale global health programs or multi-year commitments to major international organizations. This broad range reflects their commitment to supporting both foundational research and widespread implementation efforts across their core focus areas.

Investor Profile

Bill & Melinda Gates Foundation has backed more than 343 startups, with 43 new investments in the last 12 months alone. The firm has led 250 rounds, about 73% of its total and boasts 66 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 40 rounds in the past year.
  • Typical check size: $50K – $100M.

Stage Focus

  • Grant (77%)
  • Series A (6%)
  • Series B (4%)
  • Series Unknown (4%)
  • Series C (3%)
  • Seed (3%)
  • Series E (1%)
  • Series D (1%)
  • Debt Financing (1%)
  • Post Ipo Equity (1%)

Country Focus

  • United States (54%)
  • United Kingdom (9%)
  • Canada (4%)
  • India (4%)
  • Germany (4%)
  • Kenya (3%)
  • The Netherlands (3%)
  • Switzerland (2%)
  • China (1%)
  • Nigeria (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Education
  • Medical Device
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bill & Melinda Gates Foundation frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Nomura
Asia, Tokyo, Japan, Tokyo
Co-Investments: 4
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 7
Lux Capital
North America, New York, United States, New York
Co-Investments: 4
Oikocredit International
Europe, Utrecht, The Netherlands, Amersfoort
Co-Investments: 4
Omidyar Network
North America, California, United States, Redwood City
Co-Investments: 4
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 7

Which angels does Bill & Melinda Gates Foundation often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 1
Pratul Shroff
Asia, Gujarat, India, Ahmedabad
Shared Deals: 2
JR
North America, California, United States, San Francisco
Shared Deals: 2
TG
Asia, United Arab Emirates
Shared Deals: 1
VB
Europe, England, United Kingdom, London
Shared Deals: 1
EB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Bill & Melinda Gates Foundation?

Eyam Vaccines and Immunotherapeutics

Surrey, British Columbia, Canada

Eyam Vaccines and Immunotherapeutics concentrates on the investigation and creation of vaccines for defending against infectious diseases.

MedicalPharmaceuticalTherapeutics
GrantOct 27, 2025
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series BOct 22, 2025
Amount Raised: $22,400,000

C4IR Rwanda aims to create partnerships among multiple stakeholders with a primary focus on data policy and artificial intelligence.

Artificial Intelligence (AI)Public Relations
GrantOct 20, 2025
Amount Raised: $17,500,000
Monod Bio

Seattle, Washington, United States

Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.

BiotechnologyHealth CareLife ScienceMedical
GrantOct 15, 2025
Amount Raised: $750,000
VitriVax

Boulder, Colorado, United States

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

BiotechnologyMedicalMedical DeviceTherapeutics
GrantOct 14, 2025
Amount Raised: $9,900,000
NILO Therapeutics

New York, New York, United States

NILO Therapeutics is a biotechnology and therapeutics company.

BiotechnologyHealth CareTherapeuticsWellness
Series AOct 8, 2025
Amount Raised: $101,000,000
Lumen Bioscience

Seattle, Washington, United States

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

BiopharmaBiotechnologyLife Science
Series COct 8, 2025
Amount Raised: $30,000,000
Rapidemic

Leiden, Zuid-Holland, The Netherlands

Rapidemic is a developer of diagnostic kits for infectious diseases.

BiotechnologyHealth CareHealth DiagnosticsMedicalProduct Research
GrantSep 25, 2025
Amount Raised: $3,173,092
Dare Bioscience

La Jolla, California, United States

Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.

BiopharmaBiotechnologyHealth Care
GrantSep 24, 2025
Amount Raised: $499,000
Yatiri Bio

San Diego, California, United States

Yatiri Bio is a biotechnology company that delivers biomedical data solutions to the pharmaceutical industry.

BiotechnologyMedicalPharmaceutical
GrantSep 22, 2025